Back to Search
SHIPRA GOEL, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1063025294Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone.
PMID 18644829·Ann Oncol·2008
3-trial
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers.
PMID 17195945·Invest New Drugs·2007
3-trial
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors.
PMID 17693421·Ann Oncol·2007
8-other
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers.
PMID 16683205·Invest New Drugs·2006
3-trial
Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors.
PMID 14581279·Ann Oncol·2003
3-trial
A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer.
PMID 12795535·Invest New Drugs·2003
3-trial
Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies.
PMID 12393999·Am J Clin Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 5 locations total
- Address
- 462 Grider St
Buffalo, NY 14215 - Phone
- (716) 989-3000
Locations (5)
Quick Facts
- NPI
- 1063025294
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile